A notable NIH reform rolled out by Trump was a $4 billion cut to overhead funding for biomedical research by reducing ...

Equities researchers at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued on Friday. The brokerage set a “sell” rating ...

Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut ...

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...

Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication, has achieved more ...